FDA
- Status: approved
Trace lithium dose plus treatment as usual (Trace lithium dose plus treatment as usual) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
University of Chile is the originator. The local marketing authorisation holder may differ — check the official source linked above.